Literature DB >> 17296605

Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver.

Takashi Yamamoto1, Hitoshi Shimano, Noriyuki Inoue, Yoshimi Nakagawa, Takashi Matsuzaka, Akimitsu Takahashi, Naoya Yahagi, Hirohito Sone, Hiroaki Suzuki, Hideo Toyoshima, Nobuhiro Yamada.   

Abstract

Sterol regulatory element-binding protein (SREBP)-1c is a transcription factor that controls synthesis of fatty acids and triglycerides in the liver and is highly regulated by nutrition and hormones. In the current studies we show that protein kinase A (PKA), a mediator of glucagon/cAMP, a fasting signaling, suppresses SREBP-1c by modulating the activity of liver X receptor alpha (LXRalpha), a dominant activator of SREBP-1c expression. Activation of PKA repressed LXR-induced SREBP-1c expression both in rat primary hepatocytes and mouse livers. Promoter analyses revealed that the LXRalpha-binding site in the SREBP-1c promoter is responsible for PKA inhibitory effect on SREBP-1c transcription. In vitro and in vivo PKA directly phosphorylated LXRalpha, and the two consensus PKA target sites (195, 196 serines and 290, 291 serines) in its ligand binding/heterodimerization domain were crucial for the inhibition of LXR signaling. PKA phosphorylation of LXRalpha caused impaired DNA binding activity by preventing LXRalpha/RXR dimerization and decreased its transcription activity by inhibiting recruitment of coactivator SCR-1 and enhancing recruitment of corepressor NcoR1. These results indicate that LXRalpha is regulated not only by oxysterol derivatives but also by PKA-mediated phosphorylation, which suggests that nutritional regulation of SREBP-1c and lipogenesis could be regulated at least partially through modulation of LXR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296605     DOI: 10.1074/jbc.M611911200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 3.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 4.  LXRα Phosphorylation in Cardiometabolic Disease: Insight From Mouse Models.

Authors:  Maud Voisin; Matthew C Gage; Natalia Becares; Elina Shrestha; Edward A Fisher; Ines Pineda-Torra; Michael J Garabedian
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

5.  Intensity-dependent and sex-specific alterations in hepatic triglyceride metabolism in mice following acute exercise.

Authors:  Marc A Tuazon; Taylor R McConnell; Gabriel J Wilson; Tracy G Anthony; Gregory C Henderson
Journal:  J Appl Physiol (1985)       Date:  2014-09-25

6.  Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 Phosphorylation.

Authors:  Chaowei Wu; Maryem A Hussein; Elina Shrestha; Sarah Leone; Mohammed S Aiyegbo; W Marcus Lambert; Benoit Pourcet; Timothy Cardozo; Jan-Ake Gustafson; Edward A Fisher; Ines Pineda-Torra; Michael J Garabedian
Journal:  Mol Cell Biol       Date:  2015-03-30       Impact factor: 4.272

7.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

8.  Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.

Authors:  Balachandar Nedumaran; Gwang Sik Kim; Sungpyo Hong; Young-Sil Yoon; Yong-Hoon Kim; Chul-Ho Lee; Young Chul Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

9.  Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose.

Authors:  Elin Holter Anthonisen; Lise Berven; Sverre Holm; Maria Nygård; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

10.  cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.

Authors:  A-K Min; J Y Jeong; Y Go; Y-K Choi; Y-D Kim; I-K Lee; K-G Park
Journal:  Diabetologia       Date:  2012-11-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.